Dose‐dependent mathematical modeling of interferon‐α‐treatment for personalized treatment of myeloproliferative neoplasms

Abstract Long‐term treatment with interferon‐alfa (IFN) can reduce the disease burden of patients diagnosed with myeloproliferative neoplasms (MPNs). Determining individual patient responses to IFN therapy may allow for efficient personalized treatment, reducing both drop‐out and disease burden. A m...

Full description

Bibliographic Details
Main Authors: Rasmus K. Pedersen, Morten Andersen, Trine A. Knudsen, Vibe Skov, Lasse Kjær, Hans C. Hasselbalch, Johnny T. Ottesen
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Computational and Systems Oncology
Subjects:
Online Access:https://doi.org/10.1002/cso2.1030